INTK .004 (Hidden Gem)Huge Email from V.P. >> V.P. Training

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
818
INTK .004 (Hidden Gem)Huge Email from V.P. >> V.P. Training & Specifications
INI Worldwide

I can completely understand why you and your friends would have serious concerns about our company, so let me share with you as much as I can without breaking SEC rules.

We are successfully executing a difficult turnaround.

Last year, I became aware that my operations team and finance team were not taking care of business as it should be taken care of. We had problems.

I dropped all R&D projects that I was working on, my primary area of responsibility since the inception of the company in 2004, and began focusing on the basics.

1) I unloaded non-performing and underperforming personnel, which also dramatically reduced overhead as they were expensive people and that also allowed me to reduce office space, health insurance costs, etc, etc.

2) I outsourced on an “as needed” basis our accounting and operations tasks. It took some time to find the right partners and even more time to sort through the problems and address them one by one.

3) I and the remaining members of my team worked, and continue to work, 16-18 hour days, seven days a week, solely and with single minded focus on revenue and nothing but revenue. Revenue fixes everything… the unhappy customers, the backorders, the vendors, the stock market.

4) We have built a steady source of day to day revenue from general one-off sales through our marketing strategies executed consistently and daily, weekly, monthly. We are diligently and responsibly, one by one, addressing each and every problem and making things right as fast as is humanly possible.

5) We have rebuilt our international distributor network, rebuilding tattered relationships and finding new, qualified, distributors who are producing results and the only results we care about are revenue.

6) We have built a portfolio of very, very large customers who are in various stages of incorporating our products into their standard operating procedures. These are big, name brand companies that the stock market will both recognize and appreciate when we are in a position to announce them.

7) We are working on our financials to post them current as of the end of this quarter, then begin spending the money and time again on enhancing shareholder value through press releases, etc.

It is not a complicated plan to execute and this path of turning a company around is a well documented process. It does, however, take a ton of time of time and effort. Fortunately, time and effort is something that I and the remaining members of my team are absolutely willing to give to this project in whatever amount is required to get this job done.

I hope this gives you some small level of reassurance that we are not blind to the problems we have had to deal with and that we have, and are executing, a simple and straightforward strategy to create the high level of success that these products and this company are capable of.

Respectfully submitted,

Stuart Burchill, CEO/CTO
Co-Founder
INI Worldwide
1415 Panther Lane, Suite 397
Naples, FL 34109 USA

http://www.ini-worldwide.com
US & Canada: 1.800.767.3998
International: 1.239.963.1469

_______________________________________________

prior, this was another response

The company has been working very hard to build a substantial portfolio of very LARGE DEALS in a number of new market verticals as well as continuing to nurture and advance existing client relationships with large multinational companies. Our focus is creating LARGE ONGOING REVENUE STREAMS which will, in turn, increasingly enhance shareholder value for many years to come.

We do understand that this laser focus on revenue has caused a delay in our intended shareholder updates. We intend to remedy that by providing an update to shareholders soon as possible. We think you will be very pleased at our progress.

We will keep you updated and thank you for your continuing support of Industrial Nanotech.

Best regards,
Francesca

Francesca M.Crolley
V.P. Training & Specifications
INI Worldwide
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading